National and Kapodistrian University of Athens
Πολυκεντρική μελέτη καταγραφής σοβαρών μορφών πνευμονίας σε ασθενείς της ΜΕΘ
Abstract
dc:descriptionOBJECTIVE: Information on clinical practice regarding the diagnosis andmanagement of pneumonia in mechanically ventilated patients in European IntensiveCare Units (ICUs) is limited. The aim of this study was to describe the spectrum ofactual diagnostic and treatment practices for mechanically ventilated patients withpneumonia in a large sample of European ICUs.METHODS: Prospective, observational, multicenter study that took place in 27 ICUsof 9 European countries.Consecutive patients requiring invasive mechanical ventilationfor an admission diagnosis of pneumonia or on mechanical ventilation (MV) for >48hours irrespective of admission diagnosis were recruited.RESULTS: A total of 2436 ΙCU patients were evaluated; 827 were admitted to the ICUwith or developed nosocomial pneumonia (HAP: 27.1%, VAP: 56.2%, very early-VAP:16.7%), while 262 patients were admitted to the ICU with severe community-acquiredpneumonia (immunocompetent with sCAP=218). Mean age was 59.4 ±18.1 years,65.0% were men, mean admission SAPSII was 46.7±17.1. In survivors, mean length ofMV and mean ICU-LOS was significantly higher in patients with pneumonia than inICU patients without pneumonia. Mortality rate was significantly higher in nosocomialpneumonia and in sCAP than in ICU patients without pneumonia (37.7%, 38.9% and31.6%, respectively). Worsening oxygenation was the most frequent clinical sign ofboth nosocomial pneumonia pneumonia and sCAP (76.8% and 86.3%, respectively),followed by purulent secretions (72.1%) in nosocomial pneumonia and signs ofconsolidation (65.3%) in sCAP. Bronchoscopy was performed in 23.3% of patientswith nosocomial pneumonia and in 35.1% of patients with sCAP, but a very highvariability existed between the participating centers. Microbiological documentationwas obtained in 69.5% of nosocomial pneumonia patients and in 46.8% ofimmunocompetent patients with SCAP. The most common isolates in nosocomialpneumonia were Enterobacteriaceae (43.8%), Pseudomonas aeruginosa (23.1%), andAcinetobacter baumannii (19.1%), whereas, the most common isolate in ICU patientswith CAP was Streptococcus pneumoniae (31.1%), followed by Staphylococcus aureus(25.4%) and Enterobacteriaceae (23%). The choice of empirical antibiotic regimen fornosocomial pneumonia was determined by admission category, severity of illness and Acinetobacter spp basal prevalence in nosocomial pneumonia episodes >10%. Traumapatients were prescribed more often with non-antiPseudomonal cephalosporins(OR=2.68; 95%CI1.50-4.78), while surgical patients received less aminoglycosides(OR=0.26, 95%CI 0.14-0.49). Significant correlation (p<0.01) was found betweenSAPSII score and carbapenem prescription. Basal Acinetobacter spp prevalence innosocomial pneumonia episodes >10% dramatically increased the prescription ofcolistin (OR=115.7, 95%CI: 6.9-1930.9) and carbapenems (OR= 3.5, 95%CI: 2.0-6.1).Appropriate empiric antibiotics decreased ICU-LOS by 6 days (p=0.04). Mostfrequently prescribed antibiotics in the empiric treatment of nosocomial pneumoniawere carbapenems, piperacillin/tazobactam and quinolones, but antibiotic choicesvaried between the participating ICUs. From the 212 immunocompetent patients withsCAP, 165 (75.7%) had severe sepsis or septic shock. Monotherapy was given in only19.7% and combination therapy to the rest of the patients. Empirical antibiotic therapywas in accordance with the guidelines only in 100 (45.9%) patients, however, nodifferences in mortality rates were found between compliants and non-compliants. Inthis cohort, a Cox regression analysis adjusted by severity identified that macrolide usewas associated with lower ICU mortality (HR=0.48, 95%CI: 0.23-0.97, p=0.04) whencompared to the use of fluoroquinolones. The incidence of VAP did not differsignificantly in patients with or without COPD, but patients with COPD who developedVAP had longer duration of mechanical ventilation and ICU-LOS and increasedmortality compared to critically ill patients with COPD but without VAP. Elderlypatients did not have increased incidence of VAP, but multivariate analysis showed thatadvanced age was an independent risk factor for mortality from VAP.CONCLUSIONS: The current study is, till now, the first large multicenter,multinational study that described the current practice in diagnosis and management ofpneumonia in European ICUs. Etiological diagnosis of nosocomial and severecommunity-acquired pneumonia in a large sample of European ICUs was based mainlyon non-invasive techniques, however, there was a high variability in bronchoscopy usebetween the participating ICUs. Admission category, severity of illness and basalA.baumannii prevalence >10% were major determinants of empiric antibiotic choice fornosocomial pneumonia. Although a high variability existed between the participatingcenters, carbapenems were the most frequently prescribed antibiotics for the empirical treatment of nosocomial pneumonia across Europe. Only less than a half of the patientswith severe community acquired pneumonia received empirical antibiotic therapy inaccordance to ATS/IDSA guidelines, but compliance or non-compliance to guidelinesdid not affect outcome.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koulenti, Despina
- Κουλέντη, Δέσποινα
Subjects
dc:subject × 15- Μονάδα εντατικής θεραπείας ( ΜΕΘ )
- Σοβαρές μορφές πνευμονίας
- Νοσοκομειακή πνευμονία
- Πνευμονία σχετιζόμενη με το μηχανικό αερισμό
- Πνευμονία της κοινότητας
- Intensive care medicine
- Severe forms of pneumonia
- Nosocomial pneumonia
- Ventilator-associated pneumonia
- Community-acquired pneumonia
- Hospital-acquired pneumonia
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/31778